Eribulin mesylate exerts antitumor effects via CD103
Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2023-12-01
|
| Серія: | OncoImmunology |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|